Journal article
Comparing safety & immunogenicity of TB vaccine MVA85A through intramuscular and intradermal routes
New vaccines to prevent tuberculosis are urgently needed. MVA85A is a novel viral vector TB vaccine candidate designed to boost BCG-induced immunity when delivered intradermally. To date, intramuscular delivery has not been evaluated. Skin and muscle have distinct anatomical and immunological properties which could impact upon vaccine-mediated cellular immunity.
Authors
Languages
- English
Publication year
2013
Journal
Vaccine
Volume
31
Issue
7
Type
Categories
Diseases
